anti-TROP2 antibody-drug conjugate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-TROP2 antibody-drug conjugate, covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer [Phase 2]